Exact Sciences is a pioneering company dedicated to transforming cancer care through innovative testing solutions aimed at prevention, early detection, and treatment guidance. The brand is committed to eradicating cancer by leveraging science-backed insights and personalized approaches that prioritize patient well-being. Among their extensive range of products, Exact Sciences offers the Cologuard® test for colorectal cancer screening, OncoExTra® for assessing genomic alterations post-diagnosis, and the Oncotype DX® portfolio that supports treatment decisions in breast and colon cancer.

With a focus on patient convenience, Exact Sciences provides remote testing options that empower individuals to take proactive steps in their health journey. The company collaborates with leading medical experts and institutions to enhance cancer care and improve outcomes. Through rigorous research and advanced laboratory capabilities, Exact Sciences ensures proven accuracy and continuous innovation in the fight against cancer. The brand’s commitment to making a positive impact on lives and fostering a supportive community is at the heart of everything they do.